Somatostatin receptor targeting for tumor imaging and therapy

Area of Science:

• Oncology
• Radiochemistry
• Molecular Imaging

Background:

• Somatostatin receptors and ligands are established tools for cancer detection and radiotherapy.
• Radiolabeled somatostatin analogs are routinely used for imaging neuroendocrine tumors.
• Conjugates for targeted radiation therapy are in clinical trials.

Purpose of the Study:

• To review recent advancements in somatostatin receptor-targeted molecular imaging and therapy.
• To discuss novel targeting strategies for cancer detection and treatment.
• To highlight the potential of near-infrared fluorescent dye-peptide conjugates.

Main Methods:

• Review of current literature on somatostatin receptor-targeted agents.
• Analysis of developments in molecular imaging and radiotherapy conjugates.
• Discussion of emerging technologies like fluorescent dye-peptide conjugates.

Main Results:

• Somatostatin receptor targeting is a validated approach in oncology.
• Near-infrared fluorescent dye-peptide conjugates represent a promising new modality.
• These conjugates offer potential for enhanced tumor visualization and targeted therapy.

Conclusions:

• The somatostatin/somatostatin receptor system is a versatile platform for cancer imaging and therapy.
• Near-infrared fluorescent conjugates are advancing tumor detection via endoscopy, mammography, and intraoperative imaging.
• Continued research in receptor-targeted strategies holds significant promise for personalized cancer medicine.